Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
filingDate |
2016-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2019-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2019502679-A |
titleOfInvention |
Novel compounds and methods for the treatment of Alzheimer's disease and / or cerebral amyloid angiopathy |
abstract |
Described herein are novel compounds and methods for the treatment and / or prevention of cerebral amyloidosis, such as Alzheimer's disease (AD) and / or cerebral amyloid angiopathy (CAA). [Selection figure] None |
priorityDate |
2015-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |